Susquehanna International Group’s Xenetic Biosciences XBIO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-25,388
| Closed | -$66.3K | – | 7280 |
|
2025
Q1 | $66.3K | Buy |
25,388
+9,529
| +60% | +$24.9K | ﹤0.01% | 5966 |
|
2024
Q4 | $63.9K | Buy |
+15,859
| New | +$63.9K | ﹤0.01% | 5811 |
|
2023
Q2 | – | Sell |
-7,782
| Closed | -$32.1K | – | 6554 |
|
2023
Q1 | $32.1K | Buy |
7,782
+5,278
| +211% | +$21.7K | ﹤0.01% | 5536 |
|
2022
Q4 | $7.16K | Buy |
+2,504
| New | +$7.16K | ﹤0.01% | 5517 |
|
2022
Q3 | – | Sell |
-3,752
| Closed | -$30K | – | 6982 |
|
2022
Q2 | $30K | Buy |
+3,752
| New | +$30K | ﹤0.01% | 5344 |
|
2022
Q1 | – | Sell |
-12,711
| Closed | -$164K | – | 6611 |
|
2021
Q4 | $164K | Buy |
+12,711
| New | +$164K | ﹤0.01% | 5074 |
|
2019
Q4 | – | Sell |
-1,690
| Closed | -$20K | – | 4919 |
|
2019
Q3 | $20K | Buy |
+1,690
| New | +$20K | ﹤0.01% | 4291 |
|